Where the chemical imbalance theory of depression came from

For decades, depression has been widely explained as a chemical imbalance, low serotonin specifically, that antidepressants correct. A psychiatric researcher who led a major 2022 review of the evidence explains where that idea actually came from, why it doesn't hold up, and what a more accurate picture of depression looks like.

Where the theory actually came from

The idea that depression stems from low serotonin or noradrenaline was first proposed in the 1960s by researchers studying early antidepressant drugs, not from evidence of an actual chemical deficiency. Research funded by the US National Institute of Mental Health through the 1970s failed to find supporting evidence, and the theory was fading by the 1980s. It got a second life at the end of that decade when the pharmaceutical industry needed to differentiate new SSRI antidepressants from benzodiazepines, an older drug class that had become infamous for causing dependence. Framing depression as a chemical imbalance that a pill could correct, rather than simply numbing or sedating, was a far more marketable story, and it was repeated consistently enough in advertising and by medical institutions that it became widely accepted as fact.

What a major review actually found

A 2022 review pulling together the available evidence found no consistent link between low serotonin and depression. That's a notable gap: a theory repeated for decades in doctor's offices and advertising was never solidly established in the first place, and researchers had been quietly noting the lack of supporting evidence since at least the mid-2000s without it changing public messaging. Market research from a 1990s depression-awareness campaign, partly funded by the maker of Prozac, found that people's own intuitions about the causes of depression were closer to the mark than the chemical-imbalance framing that eventually replaced them: unemployment, divorce, and abuse, not a brain chemical shortfall.

Why antidepressant trials look more convincing than they are

Clinical trials do show a difference between antidepressants and placebo, but it's a small one, and there's a specific reason it may be inflated. Properly blinded trials require that neither patients nor researchers know who's getting the real drug. But antidepressants are active substances with noticeable side effects, dry mouth, nausea, emotional changes, which often tips patients off that they're getting the real treatment rather than a sugar pill. That awareness can amplify the placebo response, meaning some of the measured benefit may reflect belief in the treatment rather than a direct chemical effect on mood.

Not a sugar pill: real effects, real risks

None of this means antidepressants do nothing. They are active drugs that alter brain chemistry in ways not fully understood, and they come with real effects and real risks: emotional numbing, sexual dysfunction and reduced libido, and for some people, a difficult withdrawal process if they try to stop, sometimes described as a rebound effect, that requires tapering slowly rather than stopping abruptly. Presenting these drugs as simply correcting a known deficiency, rather than being honest that they modify normal brain function in ways still being studied, makes it harder for people to weigh those risks accurately.

A fuller picture of what actually affects mood

Treating depression as primarily biochemical tends to crowd out other well-supported contributors: unemployment, relationship loss, trauma, chronic stress, and loneliness are real drivers of low mood, not distractions from a "real" biological cause. At the same time, some biological factors do have solid evidence behind them, just not the serotonin-deficiency framework specifically. A randomized controlled trial known as the SMILES trial found that shifting from a diet of processed food to whole foods improved depression outcomes, and deficiencies in nutrients like B12, folate, vitamin D, and omega-3 fats have documented links to low mood. Exercise, meditation, adequate sleep, and lowering chronic stress all have real evidence behind them for depression, even though none of them come with the simplicity of a once-daily pill.

The takeaway

Depression is better understood as a mix of genuine life circumstances, social and economic conditions, and real but not-yet-fully-mapped biology, not a simple chemical deficiency with a one-size-fits-all fix. That reframing matters because it opens up more paths to actually improving how someone feels: addressing nutrition, movement, sleep, stress, and social connection alongside, not instead of, appropriate medical care. If you're currently taking an antidepressant, this isn't a reason to stop or change your treatment on your own, medication decisions, including how to safely taper off if that's ever the right call, should always be made with your healthcare provider. Understanding where the chemical-imbalance story came from is useful precisely because it reframes the conversation: not "what's wrong with your brain," but what in your life, body, and circumstances might genuinely be addressed.